Chinese drug makers landed 33 licensing deals with overseas pharmaceutical firms, with transactions totalling US$36.2 billion ...

On Wednesday the US announced new worldwide tariffs - including 10% on the UK. PM Keir Starmer says "nothing is off the table ...

On the FTSE 350, Watches of Switzerland is down 15%, while Vietnam focused investment trusts VinaCapital Vietnam Opportunity ...

The United States doubled down on its decades-old support for Taiwan as China flexed its muscles with a second day of ...

Multinational pharmaceutical company AstraZeneca is bullish about China's role as a global innovation powerhouse, underpinned ...

Spain ranks first in Europe for clinical trials and is attracting investment in life sciences, but faces intense competition ...

Xi said all this shows that China offers a vast stage for business development, vast market prospects, stable policy outlook, and a secure environment, making it a favored choice for foreign ...

AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...

China's president Xi Jinping recently held a meeting with 40 leaders of multinational companies, including BMW and ...

Against the backdrop of geopolitical tensions and growing waves of trade protectionism, foreign enterprises are doubling ...

US pharmaceutical giant Pfizer's new research and development (R&D) centre officially opened at BioPark in the Beijing Economic-Technological ...

China's president Xi Jinping recently held a meeting with 40 leaders of multinational companies, including BMW and ...